The podcast for evidence based medicine - where research, guidance and practice are debated and demystified

Talk Evidence
Claim This Podcastby The BMJ
Podcast Authority
Beta
Podcast Overview
The podcast for evidence based medicine - where research, guidance and practice are debated and demystified
Language
🇺🇲
Publishing Since
12/12/2018
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Talk Evidence
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

July 1, 2025
The power and the pitfalls of early diagnosis
Industry experts Peter Donnelly, Bethany Jenkins, Stuart Hogarth, Andreas Halner, Alex Richter, and Carl Heneghan examine the increasing availability of direct-to-consumer diagnostic tests and their implications for healthcare systems, discussing the need for better evaluation and regulation in this interview episode.

June 23, 2025
Gabapentinoid pain meds linked to self-harm, and getting to the Core of GRADE
Professor Seena Fazel discusses the link between gabapentinoids and self-harm with Juan Franco, while Gordon Guyatt reflects on evidence-based medicine and the Core GRADE system with Helen MacDonald in this interview episode.

April 17, 2025
The evidence on physician associates, and the evidence against back pain injections
Helen MacDonald and Juan Franco are back, magnifying glasses in hand, to take a closer look at what’s happening in evidence based medicine. In this episode: the NHS increasingly relies on physician associates to plug some of its leaks. But, what do academic studies show about the effectiveness of these newest healthcare team members? Trish Greenhalgh is professor of primary healthcare at the University of Oxford, and she tells us about her meta-study reviewing the evidence. Meanwhile, chronic back pain can be debilitating. When it’s at its worst, patients are eager for treatments. But, what is the true effectiveness of spinal injections to alleviate pain? Jane Ballantyne is a retired professor of pain medicine. She discusses where interventions go wrong, and how new recommendations for pain management reflect the best evidence. Finally, Helen and Juan face uncertainty. A new research methods and reporting paper published in the BMJ takes a critical look at clinical prediction models. What does the evidence tell clinicians about how to behave when outcomes can’t be exact? Reading list: Physician associates and anaesthetic associates in UK: rapid systematic review of recent UK based research. Spinal interventions for chronic back pain Uncertainty of risk estimates from clinical prediction models: rationale, challenges, and approaches
79 total episodes available
Recent guests on Talk Evidence
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Peter Donnelly
Guest
Bethany Jenkins
Guest
Stuart Hogarth
Guest
Andreas Halner
Guest
Alex Richter
Guest
Carl Heneghan
Guest
Seena Fazel
Guest
Gordon Guyatt
Guest
Deep-dive analytics for Talk Evidence
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Talk Evidence?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.